Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

Abdellah Mansouri, Lon D. Ridgway, Anita L. Korapati et al. · Journal of Biological Chemistry · 2003 · 384 citations · Full text

Medicine, Cancer Biology, Oncology +17

A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents.

Ricardo Sánchez‐Prieto, José M. Rojas, Yoichi Taya et al. · PubMed · 2000 · 269 citations

Life Sciences, Cell Biology, Molecular Biology +17

The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids

Jean‐Michel Revest, Francesco Di Blasi, Pierre Kitchener et al. · Nature Neuroscience · 2005 · 233 citations

Veterinary Medicine, Neurobiology, Neuroscience +14

Early Growth Response-1-dependent Apoptosis Is Mediated by p53

Prakash Nair, Sumathi Muthukkumar, Stephen F. Sells et al. · Journal of Biological Chemistry · 1997 · 171 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

Miroslav Barančı́k, V. Boháčová, Janka Kvačkajová et al. · European Journal of Pharmaceutical Sciences · 2001 · 134 citations

Life Sciences, Pharmacology, Pharmacotherapy +8